Posted on 12/19/2018 8:57 AM
CANTON, Mich. (December 19, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company will host the Michigan SAS Users Group (MSUG) for their first quarter meeting on Wednesday, March 13, 2019. At the event, members will share information on building applications with SAS Software and how to better use statistical programming tools and user interfaces.
MSUG is organized to further the interests of programmers and users of SAS Software. The event is free and open to members, students interested in programming fields, and the public.
“MSUG does an incredible job of educating our industry at the state level, and I continually encourage those on the MMS statistical programming team to participate in these insightful events,” said Jim Bademian, Global Head of Statistical Programming and Data Management, MMS. “Continual education is of the utmost importance for any statistical programmer. It is one of those fields in which you can never learn enough.”
MMS first hosted MSUG in 2012, and members of MMS remain active in the group.
“Having a corporate partner like MMS to host our quarterly meetings is key to the long-term viability and health of our group,” said Ken Schmidt, Executive Board Member, Michigan SAS Users Group. “Having our events spread at around the southeastern Michigan area allows us to foster greater networking opportunities for our members.”
The call for presentations is currently open. Submit an abstract or pre-register in advance at: http://www.misug.org/
MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards. For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
Don McLean, MBA